Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 260660298 approvals59 trials

KOREA ARLICO PHARM CO.,LTD.

Official website

Founded in 1992 and KOSDAQ-listed in 2018, Korea Arlico Pharm manufactures and markets pharmaceuticals and offers CMO services.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1992 and listed on KOSDAQ in 2018, Korea Arlico Pharm manufactures and sells pharmaceuticals and provides contract manufacturing (CMO) services. It in-licensed a 0.5-5mg ADHD/pediatric insomnia treatment from Sweden's AGB Pharma AB and a Pre-Filled Syringe from China's Jiaxing Tianhe Pharmaceutical, and signed a co-marketing agreement with Aerison Pharm for three products including a nebivolol/rosuvastatin combination drug. It recorded a 13.69% revenue CAGR from 2012 to 2025, and is developing 19 generic drugs, 3 improved new drugs (1 gastrointestinal, 2 respiratory), and 1 new ophthalmic drug.

Products & technology

  • ADHD/pediatric insomnia treatment (0.5-5mg)Treatment of pediatric ADHD and insomnia
  • Pre-Filled SyringePre-filled syringe medical device
  • Nebivolol/rosuvastatin combination drug, nebivolol tablet, nifedipine sustained-release tablet 40mgTreatment of hypertension-heart failure, hyperlipidemia, and coronary artery disease
  • Generic drugs (19 items)Generic pharmaceuticals
  • Improved new drugs (1 gastrointestinal, 2 respiratory)Treatment of gastrointestinal and respiratory diseases
  • New ophthalmic drugTreatment of ophthalmic conditions
  • ALC-2203 (novel herbal combination drug)Treatment of acute bronchitis

Regulatory approvals

data.go.kr

297 Korean MFDS drug approvals · 1979–2026 / 1 Korean MFDS device approvals · 2023

  • MFDS drugArlfliver Tab.2026-08-21
    Drug · OTC · Notification202602423
  • MFDS drugArlixaban tab. 60mg2026-08-11
    Drug · Prescription · Approval202602329
  • MFDS drugArlixaban tab. 30mg2026-08-11
    Drug · Prescription · Approval202602330
  • MFDS drugCitual Tab. 50mg2026-06-29
    Drug · Prescription · Approval202601850
  • MFDS drugPelbion Tablet2026-06-26
    Drug · Prescription · Approval202601824
  • MFDS drugArlirox-D Tab.2026-05-12
    Drug · Prescription · Approval202601385
  • MFDS drugALIVONO Tab. 20mg2026-03-11
    Drug · Prescription · Approval202600719
  • MFDS drugALIVONO Tab. 10mg2026-03-11
    Drug · Prescription · Approval202600720
  • MFDS drugARLINOXIL Tab. 5mg2026-02-19
    Drug · Prescription · Approval202600459
  • MFDS drugMUJOCLEAN Nail Lacquer2026-01-20
    Drug · OTC · Approval202600177
  • MFDS drugCres Tab. 2.5mg2026-01-12
    Drug · Prescription · Approval202600097
  • MFDS drugAllerandine Tab. 120mg(Fexofenadine Hydrochloride)2026-01-02
    Drug · OTC · Notification202600006
Show 68 more
  • MFDS drugARLBISTOL tab. 5mg2025-12-22
    Drug · Prescription · Approval202503343
  • MFDS drugARLBISTOL tab. 22.5mg2025-12-22
    Drug · Prescription · Approval202503344
  • MFDS drugAmlocande Tab.2025-12-19
    Drug · Prescription · Approval202503322
  • MFDS drugAmlocande Tab.2025-12-19
    Drug · Prescription · Approval202503323
  • MFDS drugAmlocande Tab.2025-12-19
    Drug · Prescription · Approval202503324
  • MFDS drugArliem Tab. 25/5mg2025-08-20
    Drug · Prescription · Approval202502160
  • MFDS drugArliem Tab. 10/5mg2025-08-20
    Drug · Prescription · Approval202502161
  • MFDS drugArlicoforman Soft Cap.2025-08-19
    Drug · OTC · Notification202502149
  • MFDS drugARLBISTOL tab. 1.25mg2025-07-15
    Drug · Prescription · Approval202501802
  • MFDS drugArleba SR Tablet 150mg2025-05-28
    Drug · Prescription · Approval202501329
  • MFDS drugNifedion CR Tab 40mg(Nifedipine)2025-05-22
    Drug · Prescription · Approval202501260
  • MFDS drugCREBISTA Tab. 5/10mgRevoked2025-04-30
    Drug · Prescription · Approval202501054
  • MFDS drugCREBISTA Tab. 2.5/10mgRevoked2025-04-30
    Drug · Prescription · Approval202501055
  • MFDS drugCREBISTA Tab. 2.5/5mgRevoked2025-04-30
    Drug · Prescription · Approval202501056
  • MFDS drugArlicocal D Tab.2025-03-31
    Drug · OTC · Notification202500749
  • MFDS drugArlifeb Tab. 10/160mg2025-02-27
    Drug · Prescription · Approval202500435
  • MFDS drugAlmantin Tab. 5mg2025-01-24
    Drug · Prescription · Approval202500201
  • MFDS drugAlmantin Tab. 20mg2025-01-24
    Drug · Prescription · Approval202500202
  • MFDS drugCREMEGA Soft Cap.2024-12-30
    Drug · Prescription · Approval202403093
  • MFDS drugArlico Povidone Iodide Solution 10%2024-12-13
    Drug · OTC · Notification202402957
  • MFDS drugARKANA 60mg tab.2024-12-03
    Drug · Prescription · Approval202402843
  • MFDS drugARKANA 30mg tab.2024-12-03
    Drug · Prescription · Approval202402844
  • MFDS drugLALA ACTIVE Sol.(L-Arginine-L-Aspartate Hydrate)2024-10-28
    Drug · OTC · Notification202402535
  • MFDS drugAcerenol Powder 500mg2024-10-10
    Drug · OTC · Notification202402406
  • MFDS drugDAMENDCOOL Tab.2024-09-05
    Drug · OTC · Notification202402161
  • MFDS drugXilocaina Jelly 2%2024-04-29
    Drug · Prescription · Notification202401025
  • MFDS drugLanigl duo XR Tablet 5/1000mg2024-03-12
    Drug · Prescription · Approval202400514
  • MFDS drugLanigl duo XR Tablet 2.5/1000mg2024-03-12
    Drug · Prescription · Approval202400515
  • MFDS drugNicerony Tab. 30mg2024-02-29
    Drug · Prescription · Approval202400428
  • MFDS drugChondrug alpha Tab.2024-02-06
    Drug · OTC · Notification202400271
  • MFDS drugPactramin 2X Tab.2023-12-19
    Drug · OTC · Notification202303364
  • MFDS drugGinkgorobain Cap.2023-11-29
    Drug · OTC · Notification202303236
  • MFDS drugArlico Biotin tab. 5mg2023-11-13
    Drug · OTC · Notification202303120
  • MFDSSurgical supplies2023-10-30
    Product approval · Class 1제신 23-1576 호
  • MFDS drugSINGULAL Tablet2023-08-30
    Drug · Prescription · Approval202302553
  • MFDS drugLaycelco tablet2023-08-10
    Drug · Prescription · Approval202302400
  • MFDS drugPoliarin lacto Tab.2023-05-08
    Drug · OTC · Notification202301479
  • MFDS drugArlicolidocainecream 10.56%2023-03-21
    Drug · OTC · Approval202300991
  • MFDS drugARDEWKA 60/2.5mg Tablet2022-12-27
    Drug · Prescription · Approval202204650
  • MFDS drugARDEWKA 30/2.5mg Tablet2022-12-27
    Drug · Prescription · Approval202204651
  • MFDS drugEllaliz tab. 300mg2022-06-22
    Drug · Prescription · Approval202202632
  • MFDS drugSitaglminduo XR Tablet2022-05-13
    Drug · Prescription · Approval202202015
  • MFDS drugSitaglminduo XR Tablet2022-05-13
    Drug · Prescription · Approval202202016
  • MFDS drugSitaglminduo XR Tablet2022-05-13
    Drug · Prescription · Approval202202017
  • MFDS drugDaglozin Tablet 5mg(Dapagliflozin propanediol)2022-03-04
    Drug · Prescription · Approval202200929
  • MFDS drugDaglozin Tablet 10mg(Dapagliflozin propanediol)2022-03-02
    Drug · Prescription · Approval202200913
  • MFDS drugGinkgoroba Tab. 240mg2022-01-26
    Drug · OTC · Notification202200434
  • MFDS drugDaglosita Tablet 10/100mg2022-01-12
    Drug · Prescription · Approval202200210
  • MFDS drugNexiriumduo tab. 20/800mg2021-06-30
    Drug · Prescription · Approval202104971
  • MFDS drugAlicoxib Tablet 30mg2021-03-25
    Drug · Prescription · Approval202102595
  • MFDS drugSitaglmin Tablet 50mg(Sitagliptin Hydrochloride Hydrate)2021-02-16
    Drug · Prescription · Approval202101320
  • MFDS drugSitaglmin Tab. 100mg(Sitagliptin Hydrochloride Hydrate)2021-02-16
    Drug · Prescription · Approval202101321
  • MFDS drugSitaglmin Tablet 25mg(Sitagliptin Hydrochloride Hydrate)Revoked2021-02-16
    Drug · Prescription · Approval202101319
  • MFDS drugLenomid Tablet 20mg (Leflonomide)2021-02-08
    Drug · Prescription · Approval202101187
  • MFDS drugLenomid Tablet 10mg (Leflonomide)2021-02-08
    Drug · Prescription · Approval202101188
  • MFDS drugARVAZET Tablet 10/20mg2021-01-08
    Drug · Prescription · Approval202100205
  • MFDS drugARVAZET Tablet 10/10mg2021-01-08
    Drug · Prescription · Approval202100206
  • MFDS drugARVAZET Tablet 10/40mgRevoked2021-01-08
    Drug · Prescription · Approval202100204
  • MFDS drugBenforce Tab.2020-07-29
    Drug · OTC · Notification202005495
  • MFDS drugCRESZET tab. 10/5mg2020-06-23
    Drug · Prescription · Approval202004611
  • MFDS drugCRESZET tab. 10/20mg2020-06-23
    Drug · Prescription · Approval202004612
  • MFDS drugCRESZET tab. 10/10mg2020-06-23
    Drug · Prescription · Approval202004613
  • MFDS drugARPIX tab. 5mg2020-05-28
    Drug · Prescription · Approval202004000
  • MFDS drugARPIX tab. 2.5mg2020-05-28
    Drug · Prescription · Approval202004001
  • MFDS drugPitastin Tab. 1mg2020-05-21
    Drug · Prescription · Approval202003706
  • MFDS drugCiloel SR Cap. 200mg2020-05-12
    Drug · Prescription · Approval202003437
  • MFDS drugCiloel SR Cap. 100mg2020-05-12
    Drug · Prescription · Approval202003438
  • MFDS drugMosarin SR Tab.2020-04-28
    Drug · Prescription · Approval202003165

Showing the 80 most recent of 298 records.

Clinical trials

data.go.kr

59 MFDS clinical trial authorisations · 2013–2025 (Bioequivalence 53 · Phase 1 5 · Phase 2 1)

  • BioequivalenceALC-1-24042025-09-10

    1 trial site

  • BioequivalenceALC-1-24042025-09-10

    1 trial site

  • Bioequivalence피타스틴젯정4/10밀리그램(피타바스타틴칼슘, 에제티미브)2025-09-08

    1 trial site

  • Bioequivalence알셉틴듀오정10/20밀리그램(도네페질염산염수화물,메만틴염산염)2025-08-14

    1 trial site

  • Bioequivalence펠비온정(펠루비프로펜)2025-07-24

    1 trial site

  • Bioequivalence알릭사반정60밀리그램(에독사반토실산염수화물)2025-06-09

    1 trial site

  • Phase 1ALC-22092025-06-02

    1 trial site

  • Phase 2ALC-22032024-12-23

    10 trial sites

  • Phase 1피타스틴듀오정2024-10-09

    1 trial site

  • Bioequivalence알리코우르소데옥시콜산정300밀리그램(우르소데옥시콜산)2024-05-13

    1 trial site

  • Bioequivalence알레바서방정150밀리그램(레바미피드)2024-04-23

    1 trial site

  • Bioequivalence알리엠정25/5밀리그램(엠파글리플로진, 리나글립틴)2024-03-18

    1 trial site

Show 47 more
  • Bioequivalence알레바서방정150밀리그램(레바미피드)2024-02-06

    1 trial site

  • Bioequivalence에이캡정50밀리그램(테고프라잔)2023-09-26

    1 trial site

  • Bioequivalence알리코프정2022-11-21

    1 trial site

  • Bioequivalence알카나정60밀리그램(피마사르탄칼륨삼수화물)2022-07-25

    2 trial sites

  • Phase 1ALC-21152022-07-14

    2 trial sites

  • Phase 1ALC-21152022-05-24

    2 trial sites

  • Bioequivalence하이살탄플러스정16/12.5mg2022-01-18

    2 trial sites

  • Bioequivalence암로칸데정16/10밀리그램2022-01-18

    1 trial site

  • Bioequivalence알카나정60밀리그램(피마사르탄칼륨삼수화물)2022-01-14

    2 trial sites

  • Bioequivalence피나스로정5mg(피나스테리드)2021-12-14

    2 trial sites

  • Bioequivalence콜리아틴정(콜린알포세레이트)2021-12-14

    2 trial sites

  • Bioequivalence파비어정2021-11-29

    2 trial sites

  • Bioequivalence라리칸캡슐150밀리그램(프레가발린)2021-11-09

    2 trial sites

  • Bioequivalence알레바정(레바미피드)2021-11-02

    1 trial site

  • Bioequivalence암로베틴정5밀리그램(암로디핀베실산염)2021-10-29

    1 trial site

  • Bioequivalence암로텔미정80/5밀리그램2021-10-29

    1 trial site

  • Bioequivalence글리메릴정(글리메피리드)2021-10-07

    1 trial site

  • Phase 1알듀카정60/2.5밀리그램2021-09-14

    2 trial sites

  • Bioequivalence알치옥트란정480밀리그램(알티옥트산트로메타민염)2021-09-02

    2 trial sites

  • Bioequivalence아젤란정(아젤라스틴염산염)2021-09-01

    2 trial sites

  • Bioequivalence셀코브렉스캡슐200mg(세레콕시브)2021-08-11

    2 trial sites

  • Bioequivalence싱귤라정10밀리그램(몬테루카스트나트륨)2021-08-11

    1 trial site

  • Bioequivalence하이살탄정16밀리그램2021-08-10

    2 trial sites

  • Bioequivalence파비어정250밀리그램2021-08-02

    2 trial sites

  • Bioequivalence피오글정15밀리그램(피오글리타존염산염)2021-07-29

    2 trial sites

  • Bioequivalence알러리스정(에피나스틴염산염)2021-07-05

    1 trial site

  • Bioequivalence다글로진정10밀리그램(다파글리플로진프로판디올수화물)2021-02-08

    1 trial site

  • Bioequivalence암로칸데정16/10밀리그램2021-01-27

    1 trial site

  • Bioequivalence셀코브렉스캡슐200mg(세레콕시브)2020-12-02

    1 trial site

  • Bioequivalence플루졸캡슐(플루코나졸)2020-10-08

    1 trial site

  • Bioequivalence가바로닌캡슐300mg(가바펜틴)2020-07-09

    1 trial site

  • Bioequivalence아르바정20mg(아토르바스타틴칼슘수화물)2020-06-08

    2 trial sites

  • Bioequivalence넥시리움정40밀리그램(에스오메프라졸마그네슘삼수화물)2020-06-08

    2 trial sites

  • Bioequivalence프래빅스정(클로피도그렐황산수소염)2020-04-13

    2 trial sites

  • Bioequivalence알리콕시브정30밀리그램(에토리콕시브)2020-03-17

    1 trial site

  • Bioequivalence포그렐서방정300밀리그램(사르포그렐레이트염산염)2019-02-25

    2 trial sites

  • Bioequivalence피타스틴정4밀리그램(피타바스타틴칼슘)2018-09-07

    2 trial sites

  • Bioequivalence크레스정10mg(로수바스타틴칼슘)2018-06-25

    2 trial sites

  • Bioequivalence포그렐서방정300밀리그램(사르포그렐레이트염산염)2018-03-29

    2 trial sites

  • Bioequivalence미라베그론2017-07-03

    2 trial sites

  • Bioequivalence알치옥트정480밀리그램(알티옥트산트로메타민염)2017-03-29

    2 trial sites

  • Bioequivalence베포스틴정10밀리그램(베포타스틴베실산염)2017-02-22

    2 trial sites

  • Bioequivalence에소메정40밀리그램(에스오메프라졸마그네슘이수화물)2015-11-02

    2 trial sites

  • Bioequivalence록사펜정(록소프로펜나트륨수화물)2015-10-30

    2 trial sites

  • Bioequivalence랄록사펜정60밀리그램(라록시펜염산염)2015-10-29

    2 trial sites

  • Bioequivalence프로스타캡슐4mg(실로도신)2014-11-25

    2 trial sites

  • Bioequivalence디오디핀정2013-10-29

    2 trial sites

R&D and key agreements

Source: DART corporate disclosure

제네릭의약품 · 개발중 · 19 generic drug items in development

개량신약(소화기계·호흡기계) · 소화기·호흡기 질환 · 개발중 · Developing 1 gastrointestinal and 2 respiratory improved new drugs

신약 안과용제 · 안과질환 · 개발중 · 1 new ophthalmic drug in development

ALC-2203(신조성 생약복합제) · 급성기관지염 · 임상 2상 · Clinical trial conducted through outsourcing to LSK Global PS

Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Hanmi Pharm. Co., Ltd.1 shared

KOSPI-listed pharmaceutical company behind the combination drugs Amosartan (hypertension) and Rosuzet (dyslipidemia).

NanoenTek,Inc.1 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

SHINIL PHARMACEUTICAL CO., LTD.1 shared

Shinil Pharmaceutical operates a pharmaceutical CDMO business alongside its 'Farmtree' functional cosmetics and health-food brand.

SHINPOONG PHARMACEUTICAL CO.,LTD1 shared

Founded in 1986 and listed on the KOSPI in 1990, Shinpoong Pharmaceutical manufactures antibiotics, thrombolytics, psychotropics, and anthelmintics.

Wonbiogen Co.,Ltd.1 shared

Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.

JETEMA Co.,Ltd.90

Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.

i-SENS, Inc.90

Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.

SEJONG MEDICAL Co.Ltd.,85

Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.

Noul Co., Ltd.85

Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.

DRGEM CORPORATION85

KOSDAQ-listed manufacturer of diagnostic X-ray imaging systems and core components such as generators and tubes.

LabGenomics. Co., Ltd.85

KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.

Corentec Co., Ltd.85

Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition